This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (37) Citing Articles via Google Scholar Google Scholar Articles by Luginbühl, M. Articles by Curatolo, M. Search for Related Content PubMed PubMed Citation Articles by Luginbühl, M. Articles by Curatolo, M. Related Collections Pain Pharmacology

---

ANESTHETIC PHARMACOLOGY

Modulation of Remifentanil-Induced Analgesia, Hyperalgesia, and Tolerance by Small-Dose Ketamine in Humans

Martin Luginbühl, MD^*, Andrea Gerber, MD^*, Thomas W. Schnider, PhD, Steen Petersen-Felix, PhD^*, Lars Arendt-Nielsen, PROFESSOR, and Michele Curatolo, PhD

*Department of Anesthesiology and Division of Pain Therapy, University Hospital of Bern, Switzerland; Department of Anesthesia and Intensive Care, Kantonsspital St. Gallen, Switzerland; and Center for Sensory-Motor Interaction, University of Aalborg, Aalborg, Denmark

Address correspondence to Martin Luginbühl, MD, DEAA, Department of Anesthesiology, University Hospital, CH-3010 Bern, Switzerland. Address e-mail to martin.luginbuehl{at}dkf2.unibe.ch Reprints will not be available from the authors.

Adding a small dose of ketamine to opioids may increase the analgesic effect and prevent opioid-induced hyperalgesia and acute tolerance to opioids. In this randomized, double-blinded, placebo-controlled crossover study, we investigated the effect of remifentanil combined with small concentrations of ketamine on different experimental pain models. Pain detection thresholds to single and repeated IM electrical stimulation and to repeated transcutaneous electrical stimulation, pressure pain tolerance threshold, and sedative, respiratory, and cardiovascular side effects were assessed in 14 healthy volunteers. Saline, remifentanil alone, and remifentanil combined with ketamine at target plasma concentrations of 50 or 100 ng/mL were administered in four study sessions. The ketamine infusion was started after baseline testing at a constant target concentration. Remifentanil was started after testing with ketamine alone at an initial target concentration of 1 ng/mL and then increased to 2 ng/mL and decreased to 1 ng/mL. The last test series were started 10 min after discontinuation of remifentanil. Acute remifentanil-induced hyperalgesia and tolerance were detected only by the pressure pain test and were not suppressed by ketamine. Remifentanil alone induced significant analgesia with all pain tests. Ketamine further increased the remifentanil effect only on IM electrical pain. Remifentanil at a 2 ng/mL target concentration induced a slight respiratory depression that was antagonized by ketamine. We conclude that ketamine effects on opioid analgesia are pain-modality specific.

IMPLICATIONS: Coadministration of ketamine and morphine for pain relief is still controversial. Our experimental pain study with volunteers showed that ketamine enhances opioid analgesia without increasing sedation and reduces respiratory depression. Opioid-induced hyperalgesia and tolerance were not affected by ketamine and depended on the type of nociceptive stimulus. This may explain the conflicting results on opioid tolerance in previous studies.

This article has been cited by other articles:

				Y. Xuerong, H. Yuguang, J. Xia, and W. Hailan Ketamine and Lornoxicam for Preventing a Fentanyl-Induced Increase in Postoperative Morphine Requirement Anesth. Analg., December 1, 2008; 107(6): 2032 - 2037. [Abstract] [Full Text] [PDF]

				B. Singler, A. Troster, N. Manering, J. Schuttler, and W. Koppert Modulation of Remifentanil-Induced Postinfusion Hyperalgesia by Propofol Anesth. Analg., June 1, 2007; 104(6): 1397 - 1403. [Abstract] [Full Text] [PDF]

				A. R. Absalom, M. Lee, D. K. Menon, S. R. Sharar, T. De Smet, J. Halliday, M. Ogden, P. Corlett, G. D. Honey, and P. C. Fletcher Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers Br. J. Anaesth., May 1, 2007; 98(5): 615 - 623. [Abstract] [Full Text] [PDF]

				F. C. Colpaert, K. Deseure, L. Stinus, and H. Adriaensen High-Efficacy 5-Hydroxytryptamine 1A Receptor Activation Counteracts Opioid Hyperallodynia and Affective Conditioning J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 892 - 899. [Abstract] [Full Text] [PDF]

				P. Hans, P.-Y. Dewandre, J. F. Brichant, and V. Bonhomme Comparative effects of ketamine on Bispectral Index and spectral entropy of the electroencephalogram under sevoflurane anaesthesia Br. J. Anaesth., March 1, 2005; 94(3): 336 - 340. [Abstract] [Full Text] [PDF]

				H. Schulte, A. Sollevi, and M. Segerdahl The Synergistic Effect of Combined Treatment with Systemic Ketamine and Morphine on Experimentally Induced Windup-Like Pain in Humans Anesth. Analg., June 1, 2004; 98(6): 1574 - 1580. [Abstract] [Full Text] [PDF]